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CHARACTERIZING THE INCIDENCE OF SLEEP DISORDERS 
 
IN A COHORT OF FORMER COLLEGE FOOTBALL PLAYERS 
KRISTEN MARIE DUNCAN 
ABSTRACT 
CTE is a progressive neurodegenerative disease defined by p-tau lesions in 
characteristic locations of the brain, leading to cognitive impairment as well as mood and 
behavioral dysfunction. Exposure to repetitive head impacts is a major risk factor for 
developing CTE; however, additional risk factors and secondary modulating factors, 
which may expand available treatment and prevention options, are still being elucidated. 
Studies into the glymphatic system, a system of waste clearance in the brain thought to be 
activated during sleep, have implicated glymphatic dysfunction in the clearance of toxic 
proteins like amyloid beta and hyperphosphorylated tau, as well as in cognitive decline in 
neurodegenerative disorders like Alzheimer’s Disease, bringing into question whether 
sleep, through impacting glymphatic clearance, may act as a modulating factor in the 
development of CTE. In the present study, we began to characterize the presence of sleep 
disorders and their co-morbid conditions in a cohort of former college football players to 
gain better insight into their prevalence and the health outcomes of those with sleep 
conditions. Our results found higher rates of sleep apnea in the study sample, as well as 
an association between diagnosis with sleep apnea and diagnosis with dementia, AD, 
MCI, CTE, and similar disorders. Sleep apnea was significantly associated with 
depression, anxiety, high cholesterol, and diabetes. Further research into whether sleep 
disorders exacerbate CTE pathology or clinical symptoms, and whether treatment of 
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sleep symptoms leads to better outcomes for patients with CTE, is necessary to further 
elucidate a potential connection.   
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Chronic Traumatic Encephalopathy (CTE) is a neurodegenerative disease whose 
pathognomonic signature is the perivascular deposition of hyperphosphorylated tau 
protein (p-tau) at the depths of the sulci (McKee, Cairns, et al., 2016). It presents 
clinically with behavioral and mood changes, as well as cognitive impairment 
(Montenigro et al., 2015; R. A. Stern et al., 2013). CTE has been linked to exposure to 
repetitive head impacts (RHI), such as those that occur in high-impact sports (Asken et 
al., 2016; Gavett et al., 2011; McKee, Alosco, et al., 2016; Stein et al., 2015); however, 
additional risk factors for the development of CTE and factors that modulate its clinical 
presentation are still being elucidated. 
 
HISTORY OF CTE 
In the early 1920s, Wilfred Trotter’s definition of concussion as “an essentially 
transient state due to head injury which is of instantaneous onset, manifests widespread 
symptoms of a purely paralytic kind, does not as such comprise any evidence of 
structural cerebral injury, and is always followed by amnesia for the actual moment of the 
accident” was the predominant theory of the link between traumatic brain injury and 
neurologic functioning (Trotter, 1924). Part of this definition quickly drew scrutiny when 
Cassasa reported five autopsies of patients with histories of head injuries showing signs 
of multiple perivascular hemorrhages. However, it was still thought that the incidence of 
injuries of this type following a head trauma was relatively rare (Cassasa, 1924).  
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It was several years later that Osnato and Giliberti, analyzing 100 cases of 
concussion, concluded that not only do concussions cause cerebral injury, but that in 
some cases they lead to secondary degenerative changes (Osnato & Giliberti, 1927). This 
condition, which they termed “traumatic encephalopathy,” launched a theory of RHI-
linked neurodegenerative disease that has continued to evolve with time. Martland, a 
pathologist, further expanded the field’s understanding of RHI, proposing a link between 
autopsies of boxers that showed multiple concussive hemorrhages in the brain stem and 
corona radiata and clinical symptoms commonly associated with this population. He 
described a condition he termed “punch drunk syndrome,” so called because he estimated 
it to occur in nearly half of all boxers, who were often mistaken for being intoxicated due 
to their neurological symptoms. Punch drunk was described as a clinical syndrome that 
was parkinsonian in nature, that in late stages could progress to cognitive decline 
resulting in institutionalization. Martland proposed that these symptoms could be 
explained by the development of gliosis, or progressive, degenerative lesions in patients 
that survived after sustaining initial microhemorrhages (Martland, 1928). More evidence 
for the existence of this syndrome began to accumulate, as others expanded upon a range 
of psychiatric, cognitive and physical symptoms and time courses for their presentation, 
and in 1937 Millspaugh renamed it “dementia pugilistica” (Jokl & Guttman, 1931; 
Millspaugh, 1937; Parker, 1934). Though throughout much of the twentieth century this 
was widely believed to occur only in boxers, the name Chronic Traumatic 
Encephalopathy began working its way into the literature in 1949, highlighting the 
progressive nature of the disease (Critchley, 1949, 1957).  
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The neuropathology of this disease was characterized in a study of fifteen retired 
boxers by Corsellis, et al., who used silver staining to identify neurofibrillary tangles 
present primarily in the substantia nigra and medial temporal lobe, with associated 
neuronal loss, cerebellar scarring, and septal abnormalities (Corsellis et al., 1973). Since 
then, CTE has been identified in a number of other athletes, including American-style 
football (B. Omalu et al., 2005; B. I. Omalu et al., 2006), as well as ice hockey, soccer, 
rugby, and baseball players, and military veterans without a history of playing contact 
sports (McKee et al., 2009, 2014). Other non-athletes with a history of repetitive head 
trauma have also been diagnosed with CTE, including a victim of domestic abuse, a 
person with poorly-controlled epilepsy, people who exhibit head-banging behavior, and a 
circus clown who sustained RHIs during his performances (Geddes et al., 1999; Hof et 
al., 1991; McKee et al., 2009; Roberts et al., 1990; Williams & Tannenberg, 1996). 
 
NEUROPATHOLOGY 
 In 1973, Corsellis and colleagues’ seminal paper outlined a number of identifying 
factors of CTE, including silver-staining neurofibrillary degeneration, with cerebral 
atrophy, thinning of the corpus callosum, cavum septum pellucidum with fenestrations, 
and cerebellar scarring (Corsellis et al., 1973). In the late 1990s, Geddes and colleagues 
found an association between RHI and neocortical neurofibrillary tangle formation and 
tau pathology primarily in the depths of the sulci, suggestive of blood vessel and 
perivasculature damage (Geddes et al., 1999). A series of studies describing the 
neuropathology of CTE were published in the following decades; though they reported 
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similar overall findings, not all of them agreed on specifics of a microscopic pathological 
signature for the disease (McKee et al., 2009, 2013; B. Omalu et al., 2005, 2011).  
In 2015, the first of a series of consensus meetings to set guidelines for the 
pathological diagnosis of CTE resulted in a list of specific criteria required and 
supportive for the diagnosis of CTE, as well as exclusions to the diagnosis of primary 
CTE. The consensus panel defined the pathognomonic lesion of CTE as abnormal 
perivascular aggregation of hyperphosphorylated tau (p-tau) protein in the neurons, 
astrocytes, and cell processes located at the depth of cortical sulci (McKee, Cairns, et al., 
2016). Other supportive pathologies included macroscopic septal abnormalities and third 
ventricular dilation; p-tau lesions predominantly in the more superficial layers II and III 
of the neocortex; and hippocampal p-tau deposition in areas CA2 and CA4. These last 
two findings differentiate CTE from Alzheimer’s Disease, where p-tau lesions 
preferentially appear in deeper layers 3-5 of the neocortex and in CA1 and the subiculum 
of the hippocampus (McKee, Cairns, et al., 2016). As CTE progresses, aggregates that 
are initially more commonly located in the frontal, parietal, and temporal regions of the 
brain extend become more diffuse throughout the cerebral cortex and penetrate through to 
the medial temporal lobe, diencephalon, and brain stem (McKee, Cairns, et al., 2016) 
(Mez et al., 2017).  
Though advances have been made in understanding the clinical and pathological 
presentation of CTE, it can currently only be diagnosed post-mortem. Studies using 
Positron-emission Tomography (PET) and tau-specific radioligands have shown promise 
in measuring the expression of p-tau in vivo; however, further research is needed to 
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determine the technology’s ability to reliably diagnosis CTE on the individual level (R. 
A. Stern et al., 2019). 
 
CLINICAL SYNDROME 
 In contrast to the unique and specific pathological signature of CTE, the clinical 
symptoms of the disease are highly variable and non-specific to those with CTE—
especially in advanced disease, the clinical presentation of CTE may appear similar to 
Alzheimer’s Disease or frontotemporal lobe degeneration (Gavett et al., 2010; McKee et 
al., 2009). Through retrospective analysis of pathologically-confirmed cases of CTE, 
researchers have begun to elucidate a clinical profile.  
Stern and colleagues obtained retrospective reports from next-of-kin informants 
of former athletes who were diagnosed with CTE in the absence of other 
neurodegenerative co-morbidities (R. A. Stern et al., 2013). They suggested that CTE 
presents clinically in two variations. The first subtype results primarily in mood and 
behavioral changes, and develops at a younger age—the average onset of symptoms in 
this group was 34.5 years of age. The second subtype has a later onset of symptoms, with 
an average symptom onset of 58.5 years old, and results primarily in cognitive deficits. 
The mood and behavioral subtype was significantly more likely to report being physically 
and verbally violent, explosiveness, and feeling “out of control” than the cognitive 
subtype. The most common mood features were depression, hopelessness, and to a lesser 
extent, suicidality and anxiety. The most common cognitive impairments reported were 
memory difficulties, followed by executive dysfunction, attention and concentration 
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difficulties, language impairment, and visuospatial difficulties. Montenigro and 
colleagues later found a third, “mixed subtype” of disease, presenting with a combination 
of behavioral-mood and cognitive symptoms (Montenigro et al., 2014). 
 CTE is neuropathologically-defined and p-tau pathology cannot yet be used to 
make a diagnosis in vivo. To address this, Montenigro and colleagues introduced the term 
“traumatic encephalopathy syndrome” (TES) to describe a constellation of clinical 
symptoms that represent the long-term impacts of RHI, which includes CTE as well as 
other possible conditions—the designation is not meant to be suggestive of underlying 
CTE pathology (Montenigro et al., 2014). Their diagnostic criteria was derived from a 
review of 202 previously published cases of CTE, and includes five general criteria, three 
core clinical features, and nine supportive features. All five general features must be met 
for the diagnosis of TES, including a history of RHI, no co-morbid neurological disorder 
that could account for symptoms, symptoms present for at least one year, at least one core 
clinical feature present that was not present at baseline, and at least two supportive 
features present. Core clinical features include various cognitive difficulties, behavioral 
dysregulation, and depressive mood. Supportive features include impulsivity, anxiety, 
apathy, paranoia, suicidality, headache, motor signs, a progressive decline in symptoms 
or functioning, and delayed onset of symptoms at least two years after maximal RHI 
exposure. Similar to previously outlined CTE subtypes, subtypes of TES exist depending 
on whether core and supportive features are primarily cognitive, behavioral/mood, or a 
mix of both. Additionally, a fourth subtype, TES dementia, allows for a progressive 
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decline in cognitive abilities with functional impairment in activities of daily living, with 
or without concurrent behavioral/mood symptoms.  
 
MODERATING FACTORS 
Repetitive Head Trauma 
The primary risk factor for the development of CTE is repetitive head trauma 
(Asken et al., 2016; Gavett et al., 2011; McKee, Alosco, et al., 2016). It is important to 
note that although much of the early work on dementia pugilistica and CTE focused on 
concussion exposure—and indeed, the majority of recently-documented case studies of 
CTE have occurred in individuals with a history of repetitive concussive and sub-
concussive head injuries (McKee et al., 2009, 2013; Mez et al., 2017; B. Omalu et al., 
2005)—a significant portion of cases have been reported in individuals without a history 
of prior concussion (McKee et al., 2014; Stein et al., 2015). The type and extent of brain 
injury necessary to result in CTE remains unclear, but it does appear that even sub-
concussive head impacts are sufficient to induce CTE (Stein et al., 2015). Though the 
connection between RHI and CTE is well-documented, not every athlete with RHI 
exposure goes on to develop CTE (Hazrati et al., 2013).  
Age of First Exposure 
Age of first exposure to tackle football has been shown to have an effect on CTE 
presentation. Though younger age of exposure was not associated with pathological 
severity, it did predict earlier onset of neurobehavioral symptoms—every one year 
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younger participants began tackle football predicted earlier reported cognitive and 
behavior/mood symptom onset by about two and a half years (Alosco et al., 2017). Their 
results suggest that earlier onset of RHI may reduce resiliency to later-life 
neuropathology.  
Length of Exposure 
Beyond age of first exposure, it appears that length of exposure is another 
contributing factor to pathological severity and clinical symptom presentation of CTE. 
One convenience sample of 202 donated brains of former American-style football (ASF) 
players found that all former high school players diagnosed with CTE had mild 
pathology, while college, semiprofessional, and professional players were more likely to 
have severe pathology (Mez et al., 2017). Montenigro and colleagues developed a metric 
to quantify RHI exposure from football, called the Cumulative Head Impact Index, and 
found a threshold dose-response between the index and risk for later-life cognitive 
impairment, executive dysfunction, depression, apathy, and behavioral dysregulation 
(Montenigro et al., 2017). Strikingly, Mez and colleagues found a dose-relationship 
response between duration of play of ASF and CTE neuropathology, with ASF exposure 
doubling odds of disease every 2.6 years and, among those with CTE, doubling odds of 
severe disease every 5.3 years (Mez et al., 2020). Other football-related factors that may 
affect CTE risk and disease severity include player position and the linear and rotational 




As with other neurodegenerative diseases, it is possible that gene expression can 
moderate the relationship between RHI, neuropathology, and clinical presentation. 
Apolipoprotein E (ApoE) is a low-density lipoprotein receptor that has been implicated as 
the brain’s primary source of cholesterol transport for neuronal repair (Bales et al., 2002). 
It has been found to be a major risk factor for Alzheimer’s Disease (AD), another 
neurodegenerative tauopathy with amyloid presence, and plays a role in amyloid-b (Ab) 
clearance in AD (G. Bu, 2009; Corder et al., 1993; Yu et al., 2014). It has also been 
implicated in tau neuropathology in AD, where the e4 allele isoform of ApoE appears to 
be neurotoxic and stimulate tau phosphorylation (Harris et al., 2003). Because of the 
similarities between AD and CTE, and because ApoE ε4 has been shown to mediate an 
increased rate of AD and Ab deposition following traumatic brain injury (Gavett et al., 
2011; Mayeux et al., 1995; Nicoll et al., 1995), interest in this genotype as a potential risk 
factor for CTE has grown in recent years (Gandy & Dekosky, 2012). ApoE ε4 predicts 
increased injury severity, longer recovery times, and more severe cognitive and 
behavioral deficits following TBI compared to those without the allele (Ariza et al., 2006; 
Friedman et al., 1999; Kutner et al., 2000). Studies about the prevalence of the ε4 variant 
in CTE cases have found conflicting evidence as to whether or not ε4 is more prevalent 
when compared to the general population (Maroon et al., 2015; McKee et al., 2009, 2013; 
R. A. Stern et al., 2013). A larger, prospective study may better be able to elucidate any 
potential differences in prevalence between these populations (Gandy & Dekosky, 2012). 
More recently, the ε4 allele was found to be significantly associated with Ab deposition 
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in subjects with CTE, and showed that CTE subjects with Aβ had worse pathology and 
clinical outcomes (Stein et al., 2015). It is possible that the ApoE ε4 isoform mediates a 
relationship between exposure to RHI and the severity of CTE symptoms.  
A Biopsychosocial Approach 
There is not a linear relationship between severity of CTE pathology and clinical 
symptoms; even in similarly severe pathological presentations of CTE, symptom profiles 
are variable (R. A. Stern et al., 2013). Further, because the symptoms associated with 
CTE pathology are varied and non-specific to CTE, it may be clinically more useful to 
consider them in the context of a wider, biopsychosocial model. In presenting this model, 
Asken and colleagues proposed taking into consideration the complex ways in which 
biological and social factors interact to mediate and moderate the linkage between RHI, 
neuropathological outcomes, and clinical and functional outcomes (Asken et al., 2016). 
Their model is depicted in Figure 1. In addition to the biological factors mentioned 
above, the group takes into consideration factors such as developmental environment and 
demographic factors; co-morbid neurodevelopmental disorders like learning disorders or 
ADHD; processes of normal aging; difficulty adjusting to retirement; substance abuse; 
surgeries and anesthesia; and sleep difficulties. Their model not only serves as a potential 
explanation for why some people with RHI exposure do not go on to develop CTE or 
TES or why severity of the clinical syndrome and severity of pathological findings are 
not perfectly aligned; but in considering the constellation of factors contributing to the 
severity of a person’s disease, it provides a framework for risk mitigation to the extent 
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that a person does have control over these factors, and provides hope for at least some 
symptom relief by treating co-morbid conditions.  
 
Figure 1: Biopsychosocial model of pathological and functional outcomes of 
exposure to repetitive head impacts. Arrows show one-way and bi-directional 
relationships between risk/protective factors and outcomes. Pathway A refers to the risk 
factors affecting neurobiology that mediate a relationship between RHI and pathological 
outcomes. Neuropathology can directly impact clinical and functional outcomes, 
moderated by protective factors related to cognitive reserve (Path C). Conversely, 
pathway B shows psychosocial factors that lead to clinical/functional outcomes, which if 
not treated, can worsen neuropathological outcomes or lead to changes in their own right 
(Path D). Intervention levels suggest potential ways to mitigate the risk of negative 
pathological and clinical outcomes by directly affecting biological pathways 
(Intervention Level A), targeting psychosocial factors (Intervention Level B), or limiting 
the extent to which pathology translates into clinical dysfunction (Intervention Level C). 
List of risk factors is not exhaustive. *Research on RHI suggests that risk factors are not 
causally responsible for neurofibrillary tangle distribution in CTE. (Reprinted with 
permission from Springer Nature: Neuropsychology Review. Factors Influencing Clinical 




Impact of Sleep 
The role that sleep plays in this model is complex, but is of particular interest 
because of the high prevalence of sleep disorders—in particular, obstructive sleep apnea 
(OSA)—that has been reported in current and former NFL players (Albuquerque et al., 
2010; George et al., 2003; Hyman et al., 2012; Rice et al., 2010). Known risk factors for 
obstructive sleep apnea are age, race, sex, and body-mass index (BMI), and it is likely 
these risk factors are also predictive of OSA in this population, especially in former 
players. Interestingly, the first study to compare risk of OSA in former NFL players to an 
age-, BMI-, and race-matched population still found that former players were more than 
twice as likely to develop OSA (Luyster et al., 2017).  
In some ways sleep disorders can manifest similarly to CTE. Loss of sleep 
increases risk of impulsivity and violent or aggressive behavior (Gregory et al., 2008; 
Kamphuis et al., 2012). Both OSA and insomnia have been linked to depression (Buysse, 
2004; Y.-H. Chen et al., 2013; Tsuno et al., 2005). Poor sleep quality is associated with 
cognitive decline (Cricco et al., 2001; Nebes et al., 2009). A review of 56 studies 
assessing cognitive impairments in patients with sleep disorders found sleep-related 
breathing disorders like OSA to be linked with impairments in attention span, sustained 
attention, and divided attention; while patients with insomnia showed greater impairment 
in attention span, verbal immediate memory, and vigilance (Fulda & Schulz, 2001). Other 
studies have found sleep important for memory, reaction time, and executive control 
(Diekelmann & Born, 2010; Durmer & Dinges, 2005).  
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There are several reasons to suspect that sleep disorders play some role in the 
severity of symptom presentation in CTE. As described above, sleep dysfunction and 
CTE have overlap in clinical presentation. Additionally, the connection between sleep 
disorders and other neurodegenerative diseases is well-documented. REM Sleep Behavior 
Disorder (RBD) has been implicated in the risk of developing dementia in patients with 
Parkinson’s Disease (Marion et al., 2008). OSA has also been shown to reduce global 
cognition in Parkinson’s disease (Mery et al., 2017). Sleep disorders, like insomnia, are 
common in AD and are often correlated with more severe cognitive decline (P.-L. Chen 
et al., 2012; McCurry et al., 2000). Evidence suggests that SDB may be a risk factor for 
AD and dementia, and that SDB exacerbates cognitive impairments in older adults with 
dementia (Ancoli-Israel et al., 2008; Osorio et al., 2015; Shi et al., 2018). In healthy 
elderly patients, sleep fragmentation and circadian rhythm disruption have been shown to 
increase the risk of mild cognitive impairment (MCI) and dementia (Covell et al., 2012; 
Lim et al., 2013). Interestingly, in patients already diagnosed with AD, one study 
reported a 50% chance of subsequently developing OSA, suggesting a possible role of 
OSA in AD pathogenesis (Emamian et al., 2016). 
Beyond the overlapping clinical presentations of sleep dysfunction and CTE and 
the link between sleep disorders and other neurodegenerative diseases, there are 
additional reasons to suspect that sleep disorders may play some moderating role in CTE 
pathogenesis. In a recent clinical profile of brain donors stratified into mild and severe 
CTE pathology, 27% of those with mild CTE and 46% of those with severe CTE suffered 
from OSA (Mez et al., 2017). Neuronal loss and gray matter abnormalities have been 
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described in patients with OSA as well as patients with chronic insomnia (Altena et al., 
2010; Joo et al., 2013; Nowak et al., 2006). Further, OSA has been associated with the 
accumulation of p-tau and Ab (Baril et al., 2018; X.-L. Bu et al., 2015; Bubu et al., 2019; 
Zhang et al., 2014).  
A growing theory for the underlying mechanism connecting disordered sleep to 
pathological brain processes and functional impairment is the “glymphatic system” 
(Asken et al., 2016; Iverson et al., 2019; Pillai & Leverenz, 2017). The glymphatic 
system, which functions similarly to the lymphatic system elsewhere in the body, runs 
paravascularly in the brain and is responsible for the removal of metabolic waste from 
cerebrospinal fluid and interstitial fluid, with the assistance of water transport from glial 
cells (Iliff et al., 2012, 2013; Xie et al., 2013). It is responsible for Ab clearance from the 
brain parenchyma (Iliff et al., 2012; Kress et al., 2014; Mendelsohn & Larrick, 2013). 
Glymphatic function has been shown to be impaired in both the aging brain and in 
diabetes, and has been suggested to be linked to cognitive decline and dementia in these 
populations (Benveniste et al., 2019; Jiang et al., 2017). Impaired clearance of Ab via the 
glymphatic system has been reported in patients with AD compared to individuals 
without cognitive deficits (Haydon, 2017). Notably, impairment of the glymphatic system 
was shown to promote an accumulation of p-tau after traumatic brain injury in mice (Iliff 
et al., 2014). Clearance of waste is accelerated during sleep, when interstitial space 
expands by up to 60% (Boespflug & Iliff, 2018; Iliff et al., 2013; Xie et al., 2013).  
 In the last five years, a number of researchers have postulated that the glymphatic 
system, during sleep, plays a role in CTE’s characteristic perivascular accumulation of p-
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tau in the depths of the sulci (Dadas et al., 2016; Kriegel et al., 2018; Sullan et al., 2018). 
It is conceivable that in patients exposed to RHI who also have co-morbid disordered 
sleep, these effects compound to result in worse pathological outcomes and greater 
clinical dysfunction.  
Specific Aims 
The goal of this study was to assess the prevalence of various sleep disorders in a 
cohort of former college football players. It was hypothesized that the cohort would have 
higher rates of sleep disorders, including insomnia and obstructive sleep apnea, than age-
matched controls. It was secondarily hypothesized that within the study group, players 
with sleep disorders would be more likely than those without to have comorbid 
neurodegenerative disease like dementia or mild cognitive impairment; would be more 
likely to suffer from psychological issues like anxiety and depression; and would have 
poorer measures of cardiovascular health. Finally, it was hypothesized that those with 







 This paper is based on data collected from the Independent Notre Dame 
Footballers Medical Research Project, an ongoing study conducted by the Boston 
University Centers for Alzheimer’s Disease and Chronic Traumatic Encephalopathy.  
Participants were former varsity football players at the University of Notre Dame 
who played under Coach Ara Parghesian between the years 1964-1974 and Coach Dan 
Devine between the years 1975-1980. Researchers obtained a contact list of former 
players from the Notre Dame Former Players Medical Research Association, a not-for-
profit organization begun by former players that was instrumental in recruiting, 
fundraising, and garnering the support of their fellow teammates (the organization is 
independent of Notre Dame University). Contact information for next-of-kin was used for 
deceased players.  
Of the 509 unique players appearing on a roster over the seventeen years of 
interest, contact information was obtained for 407 (79%). No contact information was 
found for 17 (14%) of former players. To meet the inclusion criteria for data analysis, a 
participant must have been on the roster during their senior year at Notre Dame. The final 




Figure 2: Flowchart of Included Sample 
 
STUDY DESIGN 
 The study was designed to take place in two phases; though this paper utilizes 
data obtained solely from Phase One of the study, Phase Two will be briefly outlined as 
well. The purpose of Phase One was to describe the general health of the study 
population. Participants who passed a brief decisional capacity test filled out the survey 
themselves; participants who did not pass or who otherwise needed assistance were asked 
to complete the survey in the presence of a next-of-kin. Whenever possible, information 
about deceased players was also obtained from a next-of-kin. Participants were asked to 
complete an online survey comprised of questions about general health status and major 
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medical conditions; neurologic disorders and diagnoses of mild cognitive impairment 
(MCI) or dementia; psychiatric and behavioral disorders; and age of onset of each 
disorder. In addition, satisfaction with life was measured by asking participants to rank 
various measures on a Likert Scale from 1-7, ranging from “strongly disagree” to 
“strongly agree”. Survey questions were based on the questionnaire from another study 
currently underway at the BU ADC and CTE Centers, the Diagnostics, Imaging, and 
Genetics Network for the Objective Study and Evaluation of Chronic Traumatic 
Encephalopathy (DIAGNOSE CTE) (manuscript pending). Player positions, as well as 
senior year height and weight were obtained from official Notre Dame football rosters. 
For deceased players, death certificates were obtained from the National Death Index, a 
computerized index of death records from state agencies, to determine specific cause of 
death.  
 Phase One participants who opted in to Phase Two of the study will be asked to 
undergo online cognitive and neuropsychiatric testing. Participants will complete online 
batteries designed to evaluate cognitive deficits commonly linked to RHI, including 
episodic memory, executive function, attention, and psychomotor speed (R. A. Stern et 
al., 2013). Additionally, participants will be asked to complete validated online surveys, 
self-reporting abilities for executive function, depression, activities of daily living, mood 
and behavior related to football, pseudobulbar affect, and apathy. By comparing 
participant scores to normative data for each of these measures, clinically significant 
differences in the study sample can be determined. Finally, in order to more completely 
characterize RHI exposure, participants will complete a brief telephone interview with a 
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member of the study staff, answering questions about their history playing football and 
other contact sports, military history, and detailed traumatic brain injury history. 
 
DATA ANALYSIS 
 When possible, the study sample was compared to RAND Health and Retirement 
Survey (HRS) data (Health and Retirement Study, 2019), matched for age, sex, and 
geographic location. Descriptive statistics were calculated for all variables. Chi-square 
tests and two-tailed Fisher’s Exact Tests, where appropriate, were used for between-
group comparisons of categorical variables, and independent-sample t-tests were used to 
evaluate between-group differences for continuous variables. Significance was set at a 
probability level of p < .05. All data analysis was conducted using SPSS Version 26.0 






DESCRIPTION OF THE SAMPLE 
 Demographics of the sample compared to HRS data are detailed in Table 1, 
below. The mean age of the sample was 66.77 (s = 4.151). 93% of the study sample was 
white. 99.6% earned a Bachelor’s degree or higher.  
Table 1: Demographics of the present cohort vs data from the Health and 
Retirement Survey 
 Notre Dame 
n = 234 
HRS Data 
n = 2507 
Age 66.77 (s = 4.151) 64.64 (s = 5.321) 
Race/Ethnicity   
     Black 6% 18% 
     White 93% 73% 
     Hispanic or Latino 0.4% 10% 
Education   
     Some college 0.4% - 
     Bachelor’s  53% - 
     Master’s 23% - 
     Professional School  21% - 
     Doctoral Degree 3% - 
Marital Status   
     Never Married 3% 6% 
     Married/Domestic Partner 85% 72% 
     Divorced/Separated 10% 17% 
     Widowed 3% 4% 
Employment Status   
     Working (full-time or part-
time) 
56% 52% 
     Retired 41% 39% 
     Disabled (permanently or  




53 (22.6%) went on to play professional football after college. This group played 
a median of 24.6 games at the professional level (IQR 0-90). 
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DIAGNOSIS PROFILE OF SAMPLE 
 Diagnoses of the study population compared to HRS data are outlined in Table 2, 
below. The study population was significantly more likely to have been diagnosed with a 
sleep disorder, c2 (1, N = 2646) = 5.609, p = .018; with sleep apnea accounting for the 
majority of this difference, c2 (1, N = 2591) = 6.010, p = .014. The study population was 
also significantly more likely to have been diagnosed with dementia, AD, CTE, MCI, or 
something similar (p = .002, two-sided Fisher’s Exact Test). 








Sleep disorder diagnosis   
     ND 62 (29%) 5.609 
     HRS 536 (22%) 1 
       .018* 
Sleep apnea diagnosis   
     ND  61 (26%) 6.010 
     HRS 463 (20%) 1 
  .014* 
Insomnia diagnosis   
     ND 2 (0.9%) .007 
     HRS 24 (1%) 1 
       .993 
RLS diagnosis#   
     ND 2 (0.9%)  
     HRS 3 (0.2%) .091 
   
Diagnosed with / treated for dementia, AD, 
CTE, MCI, or something similar# 
  
     ND 12 (5.3%)  
     HRS 43 (1.7%) .002** 
Note: Chi-square analysis used unless otherwise noted.  
#Fisher’s Exact Test was used; p-value reported only 





SLEEP DISORDER TRENDS 
Of those in the study sample who were diagnosed with sleep apnea, the average 
age of diagnosis was 57.32 (s = 9.719) (Table 3, below). 48 (78.7%) were prescribed a 
Continuous Positive Airway Pressure (CPAP) machine for treatment of their OSA, and of 
those people, 73% used CPAP nearly every night of the week.  
Table 3: Age at Diagnosis and Treatment Adherence 
 Sleep Apnea Diagnosis 
n = 61 
Age at time of diagnosis 57.32 (s = 9.719) 
Prescribed CPAP 48 (78.7%) 
Nights per week using CPAP (n = 48)  
     Do Not Use 17% 
     1-2 4% 
     3-5 6% 
     6-7 73% 
 
 Independent-samples t-tests were used to compare age and senior-year BMI 
between those in the study sample with and without OSA. Age between those with OSA 
(M = 67.21, s = 3.792) and without OSA (M = 66.65, s = 4.228) was not significantly 
different; t (196) = -1.02, p = .309. Senior-year BMI between those with (M = 27.57, s = 
2.17) and without (M = 27.72, s = 2.38) OSA was not significantly different; t (228) = 
0.449, p = .654. Race was not significantly associated with OSA diagnosis (p = .534, 
two-sided Fisher’s Exact Test). Senior year position was not significantly associated with 
OSA diagnosis, c2 (5, N = 230) = 8.070, p = .152. Whether or not a player went on to 
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play professional football was also not significantly associated with OSA diagnosis, c2 














Table 4: Co-Morbidities of Sleep Apnea 
 Dementia, AD, 






















































































Note: Chi-square analysis used unless otherwise noted.  
#Fisher’s Exact Test was used  





 Table 4, above, outlines the co-morbidities frequently occurring with an OSA 
diagnosis in the study sample. Dementia, AD, CTE, MCI, and similar disorders were 
significantly associated with OSA (p = .019, two-sided Fisher’s Exact Test), as was 
anxiety (p = .01, two-sided Fisher’s Exact Test). Depression (c2 (1, N = 224) = 11.309, p 
= .001) was moderately associated with OSA. High cholesterol was moderately 
associated with OSA (c2 (1, N = 225) = 13.970, p < .001) and diabetes was weakly 
associated with OSA (c2 (1, N = 230) = 4.000, p = .045), while hypertension was not 
associated with OSA (c2 (1, N = 226) = .386, p = .534). 
 Independent-samples t-tests were used to compare quality of life measures on a 
Likert scale between participants with and without OSA, as summarized in Table 5, 
below. Those without sleep disorders agreed significantly more strongly with the 
statements “The conditions of my life are excellent,” (t (196) = 2.932, p = .004) and “I 
am satisfied with my life,” (t (196) = 2.839, p = .005). There was no significant 
difference between rankings for “In most ways my life is close to ideal,” t (196) = 1.845, 
p = .067. 
Table 5: Satisfaction with Life by Sleep Disorder Diagnosis 
 With Sleep 
Disorder 
 Without Sleep 
Disorder    
M s  M s t p-value 
In most ways my 
life is close to ideal 5.41 1.641  5.81 1.311 1.845 .067 
The conditions of 
my life are excellent 5.34 1.538  5.94 1.199 2.932 .004** 
I am satisfied with 





 The aim of this study was to characterize the prevalence of sleep disorders and 
their co-morbid conditions in a cohort of former college football players, to gain better 
insight into who is at greater risk of developing sleep disorders, and to begin to determine 
if there are any significant differences in outcomes between those with and without sleep 
disorders. Former players whose senior seasons occurred between the years of 1964 and 
1980 answered questions about their current health status from a systems standpoint, as 
well as questions about their satisfaction with life. The health statuses of deceased former 
players or those who were unable to complete surveys on their own was collected through 
loved ones and next-of-kin.  
Results showed that the study sample was significantly more likely than an age-
matched population from the Health and Retirement Survey to have been diagnosed with 
or treated for sleep disorders, specifically sleep apnea. The study population was also 
significantly more likely to have been diagnosed with or treated for dementia, AD, CTE, 
MCI, or a similar condition. Sleep apnea was significantly associated with dementia, AD, 
CTE, MCI, and similar conditions; depression; anxiety; high cholesterol; and diabetes. 
Participants with sleep disorders did not rank themselves as highly on quality of life 





SLEEP DISORDER DIAGNOSES 
 As previously stated and as predicted, the study sample of former college football 
players were significantly more likely than an age-matched population to have been 
diagnosed with sleep apnea. This result is in line with several other studies reporting 
higher rates of OSA in current and former college and NFL players (Albuquerque et al., 
2010; George et al., 2003; Hyman et al., 2012; Rice et al., 2010). This study did not find 
significantly higher rates of insomnia in this population, as was expected based on 
previous studies reporting higher rates of insomnia in patients who had been exposed to 
chronic TBI (Verma et al., 2007). However, though just 2 (1%) of participants in this 
study reported being diagnosed or treated for insomnia by a physician, a rate that was in 
line with HRS data, 17 (7%) reported that they suffer from insomnia but had not been 
formally diagnosed. Relying solely on self-report yes or no answers rather than more 
objective measures of sleep disorder like polysomnography or multiple sleep latency 
tests, as were performed in the Verma study, is a limitation of this study and may 
partially explain the lower rates of insomnia seen in this study sample. Because such low 
rates of insomnia were reported in the study sample, further analysis on risks and co-
morbidities associated with insomnia was not possible.  
 
SLEEP APNEA ANALYSIS 
A study of former NFL players found covariates of age, BMI, and position 
(linemen vs. non-linemen) to be predictive of SDB in a cohort of former NFL players, 
though the effect of position was completely accounted for by age and BMI 
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(Albuquerque et al., 2010). The present study did not find significant differences in age 
or position between those with and without sleep apnea; however, our sample was older 
than the Albuquerque study and it is possible that this effect would be more pronounced 
in a younger, more heterogeneous population. A limitation of this study was that 
information about current BMI was not collected, though this information will be 
collected in Phase 2 of data collection and this analysis will be possible in the future. 
Senior-year BMI was not predictive of sleep apnea diagnosis.  
This study did not find race to be a significant predictor of OSA, as other studies 
have reported (Morris et al., 2019); however, as the sample was 93% white, it is likely 
that this study did not have the power to assess for group differences in a meaningful 
way. Whether or not a player went on to play professional football was also not 
significantly associated with sleep apnea, suggesting that length of time playing football 
is unrelated to a player’s risk of developing OSA.  
This study found a significant association between diagnosis with OSA and 
diagnosis or treatment for dementia, AD, MCI, CTE, or something similar. This was to 
be expected due to several previous studies reporting higher risks of dementia and MCI in 
those with frequent sleep disruption and SDB (Lim et al., 2013; Shi et al., 2018). Other 
co-morbid conditions found to be significantly associated with sleep apnea in this 
population were depression and anxiety, as also reported in previous studies (Buysse, 
2004; Y.-H. Chen et al., 2013; Tsuno et al., 2005). In addition, this study also found an 
association between sleep apnea and cardiometabolic afflictions like high cholesterol and 
diabetes. Previous studies have found increased risk of hypertension, diabetes, and high 
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cholesterol in former players with sleep apnea (Morris et al., 2019). Interestingly, this 
study did not find a significant association between sleep apnea and hypertension, though 
OSA is a well-established risk factor for hypertension (Jennum & Riha, 2009). 
 This study found that former players with sleep disorders were significantly less 
likely to report that they were satisfied with their lives, or that the conditions of their lives 
were excellent. This is consistent with previous studies that reported lower quality of life 
and elevated negative affect in response to stressors among those with sleep disruption 
(Farrell-Carnahan et al., 2013; Minkel et al., 2012).  
 
LIMITATIONS 
Out of the 446 seniors listed on rosters between 1964-1980, 238 (53%) responded 
to surveys. Though this is higher than response rates reported for cohorts of former 
professional football players (Zafonte et al., 2019), a lower N limits this study’s statistical 
power. Furthermore, issues of sampling bias and generalizability are a risk when drawing 
conclusions from self-reported data from a voluntary participatory sample.  
 
FUTURE STUDIES 
 Increasing attention is being paid to the mechanisms underlying the link between 
sleep disorders such as SDB and dementia. Several studies have associated poor sleep 
quality with cognitive decline (Cricco et al., 2001; Nebes et al., 2009). As reviewed by 
Gosselin and colleagues, it is possible that the alterations in sleep architecture and 
intermittent hypoxemia seen in OSA and other sleep disorders, when untreated, gradually 
alter the structure and functioning of the brain, increasing susceptibility to 
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neurodegeneration, and increasing vulnerability to the clinical expression of dementia 
(Gosselin et al., 2019; Rosenzweig et al., 2015; Y. Stern, 2002). If this is the case, it is 
conceivable that this effect could be compounded in football players and others with 
exposure to RHI.  
To further test the hypothesis that sleep disorders such as OSA and insomnia 
serve as additional risk or modifying factors for the development and presentation of 
CTE, further research is needed to determine whether those with TES and co-morbid 
sleep conditions have more severe mood and behavioral symptoms and cognitive 
impairment than patients with TES alone. As we get closer to being able to diagnose CTE 
in vivo (R. A. Stern et al., 2019), prospective studies into whether athletes with sleep 
disorders develop symptoms and CTE pathology at a younger age or to a more severe 
level would be insightful. For now, as CTE can only be definitively diagnosed post-
mortem, studies can focus on whether participants with sleep disorders have more severe 
CTE pathology post-mortem than those without co-morbid sleep disorders. Finally, if an 
association is determined, additional research into whether modulating sleep dysfunction, 
for example, through treatment of OSA with CPAP, leads to improvement in the clinical 





 CTE is a progressive neurodegenerative disease defined by p-tau lesions in 
characteristic locations in the brain, that leads to cognitive impairment as well as mood 
and behavioral dysfunction in those affected. It can only be diagnosed post-mortem and 
there is no cure. A biopsychosocial approach to the disease that takes into consideration 
additional risk and modulating factors can expand available treatment and prevention 
options. Studies focusing on the connection between sleep dysfunction and other 
neurodegenerative disorders have laid the foundation for conjecture into whether sleep 
may serve as an additional modifying or risk factor for CTE. In this study, we 
characterized the presence of sleep disorders and their co-morbid conditions in a cohort 
of former college football players to gain insight into prevalence and who is at greater 
risk of developing a sleep condition. Our results found higher rates of sleep apnea in the 
study sample, as well as an association between diagnosis with sleep apnea and diagnosis 
with dementia, AD, MCI, CTE, and similar disorders. Sleep apnea was significantly 
associated with depression, anxiety, high cholesterol, and diabetes. Further research into 
whether sleep disorders exacerbate CTE pathology or clinical symptoms, and whether 
treatment of sleep symptoms leads to better outcomes for patients with CTE, is necessary 
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